Researchers have developed a new toolkit for detecting trypanosome parasites in livestock, aiding efforts to monitor and ...

For the first time, patients in Malawi can take a pill ... The disease—officially known as human African trypanosomiasis (HAT)—is caused by a parasite that attacks the central nervous system.

In patients with human African trypanosomiasis, trypanosomes are observed early in the inoculation chancre and in lymph nodes, from where they disseminate into the blood. In the blood, long slender ...

Human African trypanosomiasis (HAT), or sleeping sickness ... Screening of people at risk helps identify patients earlier in the disease development. If diagnosis is made early, it is possible to ...

Human African trypanosomiasis (HAT), or sleeping sickness ... Screening of people at risk helps identify patients earlier in the disease development. If diagnosis is made early, it is possible ...

Sleeping sickness, or African trypanosomiasis ... As the disease progresses, patients experience severe insomnia at night coupled with excessive daytime drowsiness. Without treatment, the ...

Currently, no vaccine or prophylactic drug exists for African trypanosomiasis ... After treatment, patients should be closely monitored for 24 months for any signs of relapse, as parasites ...

Published by Elsevier Ltd. Human African trypanosomiasis is a neglected tropical disease ... evaluated in a small number of individuals with rhodesiense HAT, all treated patients must be closely ...

The Rhodesiense strain of Human African Trypanosomiasis is nearly 100% fatal ... "This first use of PAX-101 to treat a critically ill patient with Stage 1 HAT infection is an important milestone ...